On real-time estimates of blood glucose levels: response to Trevino. by Gibson, O, Farmer, A, McSharry, P, Tarassenko, L

Effects of carnosine supplementation on glucose metabolism: Pilot clinical trial by de Courten, B, Jakubova, M, de Courten, M, Kukurova, I, Vallova, S, Krumpolec, P, Valkovic, L, Kurdiova, T, Garzon, D, Barbaresi, S, Teede, H, Derave, W, Krssak, M, Aldini, G, Ukropec, J, Ukropcova, B

“…Insulin sensitivity and secretion, glucose tolerance (oral glucose tolerance test), blood pressure, plasma lipid profile, skeletal muscle ((1) H-MRS), and urinary carnosine levels were measured.Carnosine concentrations increased in urine after supplementation (P < 0.05). …”

Augmentation of glucose metabolism with perhexiline in non-ischaemic heart failure by Lee, L, Scheurmann-Freestone, M, Campbell, R, Field, R, Gunaruwan, P, Horowitz, J, Clarke, K, Frenneaux, M

Glucose turnover in the post-absorptive rat and the effects of halothane anaesthesia. by Heath, D, Frayn, K, Rose, J

“…Rates and rate coefficients of glucose utilization and replacement in post-absorptive rats, either conscious or under halothane anaesthesia, were determined in a thermoneutral environment by using [5-3H]- and [U-14C]glucose. …”

Evaluation of a self-administered oral glucose tolerance test by Bethel, M, Holman, R

Parallel changes of proinsulin and islet amyloid polypeptide in glucose intolerance. by MacNamara, C, Barrow, B, Manley, SE, Levy, J, Clark, A, Turner, R

“…To determine if islet amyloid polypeptide (IAPP) secretion is disproportionate with other beta-cell products at any stage of glucose intolerance, 116 subjects were studied. Non-diabetic subjects with equivalent body mass index (BMI) were assigned to three groups, (i) normal fasting glucose, fpg<5.5 mmol l(-1); (ii) intermediate fasting glucose, fpg> or =5.5<6.15 mmol l(-1); (iii) impaired fasting glucose (IFG), fpg> or =6.1<7.0 mmol l(-1). …”

Opposite associations of aortic aneurysm with blood glucose and with diabetes mellitus by Morris, D, Sherliker, P, Clack, R, Preiss, D, Lam, K, Carter, J, Halliday, A, Peto, R, Lewington, S, Bulbulia, R

Periodontal ageing and its management via pharmacological glucose modulation by Neves, VCM, Savchenko, V, Daly, J, Sharpe, P

“…Yet the never-ending battle of bacteria and the gingiva involves a complex interplay between genetic, microbial and environmental factors, demanding innovative approaches to improve prevention and stabilisation of this disease. Glucose is the body's source of energy and research has shown that dysregulation of the glucose metabolism impacts PD establishment and progression, as well as impact development of systemic non communicable diseases. …”

A method for assessing quality of control from glucose profiles. by Hill, N, Hindmarsh, P, Stevens, R, Stratton, I, Levy, J, Matthews, DR

“…CONCLUSIONS: The GRADE score of a glucose profile summarises the degree of risk associated with a glucose profile. …”

Genetic determinants of glucose-6-phosphate dehydrogenase activity in Kenya by Shah, S, Macharia, A, Makale, J, Uyoga, S, Kivinen, K, Craik, R, Hubbart, C, Wellems, T, Rockett, K, Kwiatkowski, D, Williams, T

“… <p style="text-align:justify;"> <b>Background:</b> The relationship between glucose-6-phosphate dehydrogenase (G6PD) deficiency and clinical phenomena such as primaquine-sensitivity and protection from severe malaria remains poorly defined, with past association studies yielding inconsistent and conflicting results. …”

Feasibility of using laboratory glucose to diagnose undiagnosed diabetes in hospital by Farmer, A, Shine, B, Armitage, L, Murphy, N, James, T, Guha, N, Rea, R

“…We calculated an estimated proportion of individuals in each blood glucose stratum without a follow-up HbA1c who could have undiagnosed diabetes.…”

EFFECTS OF METFORMIN ON GLUCOSE UPTAKE BY ISOLATED HUMAN SKELETAL-MUSCLE by Adnitt, P, Frayn, K, Turner, P

A non-invasive frequent home blood glucose monitor by Lenzen, H, Barrow, B, White, S, Holman, R

“…They felt that the device facilitated continuous blood glucose monitoring and thought that high and low glucose alarms were helpful. …”

Diabetes mellitus, fasting glucose, and risk of cause-specific death. by Seshasai, SR, Kaptoge, S, Thompson, A, Di Angelantonio, E, Gao, P, Sarwar, N, Whincup, P, Mukamal, K, Gillum, R, Holme, I, Njølstad, I, Fletcher, A, Nilsson, P, Lewington, S, Collins, R, Gudnason, V, Thompson, S, Sattar, N, Selvin, E, Hu, F, Danesh, J

“…METHODS: We calculated hazard ratios for cause-specific death, according to baseline diabetes status or fasting glucose level, from individual-participant data on 123,205 deaths among 820,900 people in 97 prospective studies. …”

[Possible contribution of hyperglycemia in utero to glucose homeostasis disorders in the adult] by Ktorza, A, Gauguier, D, Bihoreau, M, Berthault, M, Marfaing, P, Penicaud, L

Urine analysis for glucose and protein: are the requirements of the new contract sensible? by Mant, D, Fowler, G

Evaluation of a self-administered oral glucose tolerance test. by Bethel, M, Price, H, Sourij, H, White, S, Coleman, R, Ring, A, Kennedy, I, Tucker, L, Holman, R

“…OBJECTIVE: To assess the feasibility of using a disposable, self-administered, capillary blood sampling oral glucose tolerance test (OGTT) device in a community setting. …”

Follow-up of intensive glucose control in type 2 diabetes. by Lund, S, Rossing, P, Vaag, A

Milder phenotypes of glucose transporter type 1 deficiency syndrome. by Anand, G, Padeniya, A, Hanrahan, D, Scheffer, H, Zaiwalla, Z, Cox, D, Mann, N, Hewertson, J, Price, S, Nemeth, A, Arsov, T, Scheffer, I, Jayawant, S, Pike, M, McShane, T

“…Glucose transporter type 1 deficiency syndrome (GLUT1DS) is a treatable condition resulting from impaired glucose transport into the brain. …”

Pen-sized digital 30-second blood glucose meter. by Matthews, DR, Holman, R, Bown, E, Steemson, J, Watson, A, Hughes, S, Scott, D